Sample enrichment for clinical trials to show delay of onset in huntington disease

Overview of attention for article published in Movement Disorders, January 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 3 news outlets

facebook: 1 Facebook page

Readers on

mendeley: 52 Mendeley

So far, Altmetric has seen 3 news stories from 3 outlets.

Inhibikase Therapeutics Appoints Leading Experts in Parkinson's Disease to its Scientific Advisory ...

Medical Health News, 05 Mar 2019

(GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc., a pharmaceutical company developing protein kinase inhibitors for the…

Inhibikase Therapeutics Appoints Leading Experts in Parkinson’s Disease to its Scientific Advisory Board

Morning Star, 05 Mar 2019

(GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc., a pharmaceutical company developing protein kinase inhibitors for the…

Inhibikase Therapeutics Appoints Leading Experts in Parkinsons Disease to its Scientific Advisory Board

Bioportfolio, 05 Mar 2019

(GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc., a pharmaceutical company developing protein kinase inhibitors for the…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.